Warning letterFDA · Sep 4, 2018
Mitra Distributing Inc. MARCS-CMS 562402, September 04, 2018
Named company: Mitra Distributing Inc.
Furthermore, these products are misbranded drugs under section 502 of the FD&C Act, 21 U.S.C. 352. The marketing and sale of unapproved opioid addiction treatment products is a potentially significant threat…
